Suppr超能文献

新型抗癌药物酒石酸长春瑞滨在小鼠、大鼠和犬静脉注射后的处置情况。

Disposition of the novel anticancer agent vinorelbine ditartrate following intravenous administration in mice, rats and dogs.

作者信息

Kobayashi S, Sakai T, Dalrymple P D, Wood S G, Chasseaud L F

机构信息

Pharmaceutical Research Laboratories, Kyowa Hakko Kogyo Co., Ltd., Shizuoka, Japan.

出版信息

Arzneimittelforschung. 1993 Dec;43(12):1367-77.

PMID:8141830
Abstract
  1. KW-2307 (vinorelbine ditartrate, CAS71486-22-1) is a new semisynthetic antitumour vinca alkaloid. Its pharmacokinetics, distribution and excretion were investigated following intravenous administration to mice (1.2 mg/kg), rats (0.12 and 1.2 mg/kg) and dogs (0.4 mg/kg). Dose levels are expressed as the free base. 2. Plasma concentrations of drug-related radioactivity declined in a bi- or tri-exponential manner, initially rapidly and then slowly (half-life of 35 h or more). Unchanged drug concentrations declined with terminal half-lives of 35.8 h in rats and 34.5h in dogs: a terminal phase was not observed in mice. KW-2307 can be characterised as a drug of high clearance (3.78, 1.73 and 1.20 l/h/kg in the mice, rats and dogs, respectively) and large volume of distribution (12.7, 41.9 and 49.6 l/kg in the mouse, rat and dog, respectively). After repeated administrations for 21 days in the rat, the accumulation ratio for unchanged drug concentrations in plasma was 1.5. 3. The extent of binding of 3H-KW-2307 in vitro to proteins in the plasma of humans, dogs, rats and mice was 89, 90, 93 and 97%, respectively. 4. In rats, concentrations of radioactivity in most tissues exceeded those in plasma, and at 0.5 h after administration were greatest in the adrenals, thyroid, pituitary, lungs, small intestine contents and kidneys. The lung is a target for drug action. Concentrations of radioactivity in the brain were lowest. In pregnant rats, placental transfer of radioactivity was low, less than 1% of the dose. Concentrations in mammary tissue, another target for drug action, exceeded those in plasma. The tissue distribution profile of radioactivity in rats was similar after single and repeated administrations. 5. Radioactivity was excreted mainly in faeces (61-73% dose in 48 h and 71-79% dose in 168 h). Biliary excretion accounted for 42.6% dose in rats during 48 h although enterohepatic cycling was probably unimportant.
摘要
  1. KW - 2307(酒石酸长春瑞滨,CAS71486 - 22 - 1)是一种新型半合成抗肿瘤长春花生物碱。对小鼠(1.2毫克/千克)、大鼠(0.12毫克/千克和1.2毫克/千克)和犬(0.4毫克/千克)静脉给药后,研究了其药代动力学、分布和排泄情况。剂量水平以游离碱表示。2. 与药物相关的放射性血浆浓度呈双指数或三指数方式下降,最初迅速,然后缓慢(半衰期为35小时或更长)。原形药物浓度下降,大鼠的终末半衰期为35.8小时,犬为34.5小时:在小鼠中未观察到终末相。KW - 2307的特征为清除率高(小鼠、大鼠和犬分别为3.78、1.73和1.20升/小时/千克)和分布容积大(小鼠、大鼠和犬分别为12.7、41.9和49.6升/千克)。在大鼠中重复给药21天后,血浆中原形药物浓度的蓄积比为1.5。3. 体外3H - KW - 2307与人、犬、大鼠和小鼠血浆中蛋白质的结合程度分别为89%、90%、93%和97%。4. 在大鼠中,大多数组织中的放射性浓度超过血浆中的浓度,给药后0.5小时,肾上腺、甲状腺、垂体、肺、小肠内容物和肾脏中的放射性浓度最高。肺是药物作用的靶点。脑中的放射性浓度最低。在妊娠大鼠中,放射性的胎盘转运较低,低于剂量的1%。乳腺组织是药物作用的另一个靶点,其放射性浓度超过血浆中的浓度。大鼠单次和重复给药后放射性的组织分布情况相似。5. 放射性主要经粪便排泄(48小时内排泄剂量的61% - 73%,168小时内排泄剂量的71% - 79%)。大鼠48小时内胆汁排泄占剂量的42.6%,尽管肠肝循环可能不重要。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验